{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T19:29:28Z","timestamp":1697484568999},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T00:00:00Z","timestamp":1237420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s10549-009-0368-3","type":"journal-article","created":{"date-parts":[[2009,3,18]],"date-time":"2009-03-18T06:02:51Z","timestamp":1237356171000},"page":"575-581","source":"Crossref","is-referenced-by-count":2,"title":["No evidence of familial correlation in breast cancer metastasis"],"prefix":"10.1007","volume":"118","author":[{"given":"Alice S.","family":"Whittemore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Stearman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vickie","family":"Venne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Felberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Daly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saundra S.","family":"Buys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,19]]},"reference":[{"key":"368_CR1","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.1073\/pnas.0710331105","volume":"105","author":"NP Crawford","year":"2008","unstructured":"Crawford NP, Alsarraj J, Lukes L et al (2008) Bromodomain 4 activation predicts breast cancer survival. Proc Natl Acad Sci USA 105:6380\u20136385. doi: 10.1073\/pnas.0710331105","journal-title":"Proc Natl Acad Sci USA"},{"key":"368_CR2","first-page":"8866","volume":"61","author":"KW Hunter","year":"2001","unstructured":"Hunter KW, Broman KW, Voyer TL et al (2001) Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. Cancer Res 61:8866\u20138872","journal-title":"Cancer Res"},{"key":"368_CR3","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng1635","volume":"37","author":"YG Park","year":"2005","unstructured":"Park YG, Zhao X, Lesueur F et al (2005) Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Nat Genet 37:1055\u20131062. doi: 10.1038\/ng1635","journal-title":"Nat Genet"},{"key":"368_CR4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02789239","volume":"24\u201325","author":"SA Eccles","year":"1994","unstructured":"Eccles SA, Box G, Court W et al (1994) Preclinical models for the evaluation of targeted therapies of metastatic disease. Cell Biophys 24\u201325:279\u2013291","journal-title":"Cell Biophys"},{"key":"368_CR5","first-page":"298","volume":"60","author":"R Heimann","year":"2000","unstructured":"Heimann R, Lan F, McBride R et al (2000) Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res 60:298\u2013304","journal-title":"Cancer Res"},{"key":"368_CR6","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1200\/JCO.1995.13.5.1144","volume":"13","author":"CA Quiet","year":"1995","unstructured":"Quiet CA, Ferguson DJ, Weichselbaum RR et al (1995) Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol 13:1144\u20131151","journal-title":"J Clin Oncol"},{"key":"368_CR7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1200\/JCO.1989.7.3.355","volume":"7","author":"PP Rosen","year":"1989","unstructured":"Rosen PP, Groshen S, Saigo PE et al (1989) A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 7:355\u2013366","journal-title":"J Clin Oncol"},{"key":"368_CR8","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1200\/JCO.2007.12.6425","volume":"26","author":"LK Tan","year":"2008","unstructured":"Tan LK, Giri D, Hummer AJ et al (2008) Occult axillary node metastasis in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol 26:1803\u20131809. doi: 10.1200\/JCO.2007.12.6425","journal-title":"J Clin Oncol"},{"key":"368_CR9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(05)17947-1","volume":"365","author":"Y Wang","year":"2005","unstructured":"Wang Y, Klijn JGM, Zhang Y et al (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365:671\u2013679","journal-title":"Lancet"},{"key":"368_CR10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF02303667","volume":"4","author":"SE Clare","year":"1997","unstructured":"Clare SE, Sener SF, Wilkens W et al (1997) Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol 4:447\u2013451. doi: 10.1007\/BF02303667","journal-title":"Ann Surg Oncol"},{"key":"368_CR11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1200\/JCO.2000.18.3.591","volume":"18","author":"R Heimann","year":"2000","unstructured":"Heimann R, Hellman S (2000) Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol 18:591\u2013599","journal-title":"J Clin Oncol"},{"key":"368_CR12","doi-asserted-by":"crossref","first-page":"R375","DOI":"10.1186\/bcr801","volume":"6","author":"EM John","year":"2004","unstructured":"John EM, Hopper JL, Beck JC et al (2004) The breast cancer family registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 6:R375\u2013R389. doi: 10.1186\/bcr801","journal-title":"Breast Cancer Res"},{"key":"368_CR13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/biomet\/77.3.642","volume":"77","author":"LP Zhao","year":"1990","unstructured":"Zhao LP, Prentice RL (1990) Correlated binary regression using a quadratic exponential model. Biometrika 77:642\u2013648. doi: 10.1093\/biomet\/77.3.642","journal-title":"Biometrika"},{"key":"368_CR14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/biomet\/84.2.349","volume":"84","author":"RL Prentice","year":"1997","unstructured":"Prentice RL, Hsu L (1997) Regression on hazard ratios in multivariate failure analysis. Biometrika 84:349\u2013363. doi: 10.1093\/biomet\/84.2.349","journal-title":"Biometrika"},{"key":"368_CR15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/biomet\/65.1.141","volume":"65","author":"DG Clayton","year":"1978","unstructured":"Clayton DG (1978) A model for association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence. Biometrika 65:141\u2013151. doi: 10.1093\/biomet\/65.1.141","journal-title":"Biometrika"},{"key":"368_CR16","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/bcr1737","volume":"9","author":"M Hartman","year":"2007","unstructured":"Hartman M, Lindstr\u00f6m L, Dickman PW et al (2007) Is breast cancer prognosis inherited? Breast Cancer Res 9:R39. doi: 10.1186\/bcr1737","journal-title":"Breast Cancer Res"},{"key":"368_CR17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10549-007-9692-7","volume":"110","author":"K Hemminki","year":"2007","unstructured":"Hemminki K, Ji J, F\u00f6rsti A et al (2007) Survival in breast cancer is familial. Breast Cancer Res Treat 110:177\u2013182. doi: 10.1007\/s10549-007-9692-7","journal-title":"Breast Cancer Res Treat"},{"key":"368_CR18","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S1470-2045(07)70282-6","volume":"8","author":"LS Lindstrom","year":"2007","unstructured":"Lindstrom LS, Hall P, Hartman M et al (2007) Familial concordance in cancer survival: a Swedish population-based study. Lancet Oncol 8:1001\u20131006. doi: 10.1016\/S1470-2045(07)70282-6","journal-title":"Lancet Oncol"},{"key":"368_CR19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/jnci\/94.7.490","volume":"94","author":"CJ Bradley","year":"2002","unstructured":"Bradley CJ, Given CW, Roberts C (2002) Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94:490\u2013496","journal-title":"J Natl Cancer Inst"},{"key":"368_CR20","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1002\/ijc.22979","volume":"121","author":"SO Dalton","year":"2007","unstructured":"Dalton SO, Ross L, D\u00fcring M et al (2007) Influence of socioeconomic factors on survival after breast cancer\u2013a nationwide cohort study of women diagnosed with breast cancer in Denmark 1983\u20131999. Int J Cancer 121:2524\u20132531. doi: 10.1002\/ijc.22979","journal-title":"Int J Cancer"},{"key":"368_CR21","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8","volume":"77","author":"T Lifsted","year":"1998","unstructured":"Lifsted T, Le Voyer T, Williams M et al (1998) Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer 77:640\u2013644. doi: 10.1002\/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8","journal-title":"Int J Cancer"},{"key":"368_CR22","doi-asserted-by":"crossref","first-page":"R16","DOI":"10.1186\/bcr1389","volume":"8","author":"NP Crawford","year":"2006","unstructured":"Crawford NP, Ziogas A, Peel DJ et al (2006) Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer. Breast Cancer Res 8:R16","journal-title":"Breast Cancer Res"},{"key":"368_CR23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2407-8-32","volume":"8","author":"S Costa","year":"2008","unstructured":"Costa S, Pinto D, Pereira D et al (2008) Importance of TP53 codon 72 and intron 3 duplication 16\u00a0bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer 8:32. doi: 10.1186\/1471-2407-8-32","journal-title":"BMC Cancer"},{"key":"368_CR24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-3163-4-13","volume":"4","author":"CR Hoyal","year":"2005","unstructured":"Hoyal CR, Kammerer S, Roth RB et al (2005) Genetic polymorphisms in DPF3 associated with risk of breast cancer and lymph node metastases. J Carcinog 4:13\u201321. doi: 10.1186\/1477-3163-4-13","journal-title":"J Carcinog"},{"key":"368_CR25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/FPC.0b013e328011abaa","volume":"17","author":"SH Nordgard","year":"2007","unstructured":"Nordgard SH, Ritchie MD, Jensrud SD et al (2007) ABCB1 and GST polymorphisms associated with TP53 status in breast cancer. Pharmacogenet Genomics 17:127\u2013136","journal-title":"Pharmacogenet Genomics"},{"key":"368_CR26","first-page":"3052","volume":"62","author":"EL Goode","year":"2002","unstructured":"Goode EL, Dunning AM, Kuschel B, Healey CS, Day NE, Ponder BAJ, Easton DF, Pharoah PPD et al (2002) Effect of germ-line genetic variation on breast cancer survival in a population-based study. Cancer Res 62:3052\u20133057","journal-title":"Cancer Res"},{"key":"368_CR27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1200\/JCO.2006.06.3024","volume":"25","author":"MK Schmidt","year":"2007","unstructured":"Schmidt MK, Tollenaar RAEM, de Kemp SR et al (2007) Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation. J Clin Oncol 25:64\u201369. doi: 10.1200\/JCO.2006.06.3024","journal-title":"J Clin Oncol"},{"key":"368_CR28","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1200\/JCO.2006.10.0099","volume":"25","author":"M Udler","year":"2007","unstructured":"Udler M, Maia AT, Cebrian A et al (2007) Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer. J Clin Oncol 25:3015\u20133023. doi: 10.1200\/JCO.2006.10.0099","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0368-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-009-0368-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0368-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:32:16Z","timestamp":1559233936000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-009-0368-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,19]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1007\/s10549-009-0368-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,19]]}}}